Immediate Impact
64 standout
Citing Papers
A Phase 2 Randomized Trial of Survodutide in MASH and Fibrosis
2024 Standout
Triple hormone receptor agonist retatrutide for metabolic dysfunction-associated steatotic liver disease: a randomized phase 2a trial
2024 Standout
Works of Ramchandra Ranvir being referenced
Coagonist of GLP-1 and Glucagon Receptor Ameliorates Development of Non-Alcoholic Fatty Liver Disease
2018
Coagonist of glucagon-like peptide-1 and glucagon receptors ameliorates nonalcoholic fatty liver disease
2018
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Ramchandra Ranvir | 155 | 74 | 218 | 125 | 14 | 369 | |
| Akshyaya Rath | 153 | 45 | 189 | 79 | 9 | 339 | |
| Clare A. Balendran | 111 | 67 | 147 | 80 | 11 | 376 | |
| Yi-Ning Dai | 90 | 73 | 191 | 103 | 11 | 381 | |
| Kyoko Yonemitsu | 94 | 86 | 284 | 114 | 10 | 408 | |
| Woo-Kyu Jeon | 104 | 116 | 151 | 85 | 14 | 358 | |
| Marine Halbron | 110 | 73 | 290 | 211 | 16 | 410 | |
| Takeru Sakai | 122 | 62 | 186 | 70 | 11 | 376 | |
| Caroline C. Duwaerts | 75 | 50 | 221 | 85 | 20 | 386 | |
| A. Provenzano | 71 | 47 | 216 | 61 | 15 | 369 | |
| Anna Bobrus‐Chociej | 93 | 57 | 218 | 101 | 25 | 336 |
All Works
Loading papers...